Grifols SA
Price
Unknown
Today
-1.4%
YTD
+3.4%
Grifols SA is a global healthcare company focused on improving the health and well-being of patients through innovative treatments. Based in Spain, the company's primary business involves the research, development, manufacturing, and distribution of plasma-derived medicines and transfusional diagnostic solutions, serving patients worldwide. Within the global healthcare and biotechnology sectors, Grifols SA concentrates on producing vital plasma derivatives to treat rare and chronic conditions. The company's comprehensive portfolio also encompasses advanced diagnostic systems and laboratory supplies, aiming to enhance blood safety. Explore GRF.MC share prices and other stocks on eToro. This content was generated by artificial intelligence. We cannot guarantee the accuracy, completeness, or timeliness of the information provided.
Open positions
0
Unrealized return
+0.0%
No open positions exist for this instrument at the moment.
Valuation
Profitability
Earnings & Revenue
Dividends & Risk
Closed trades
0
Realized return
+0.0%
No stored closed trades exist for this instrument yet.